Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).


TSX:MSCL - Post by User

Comment by Alba1314on Jul 20, 2018 7:53am
119 Views
Post# 28343205

RE:RE:Why are news delayed???

RE:RE:Why are news delayed???
HouseSpeaker007 wrote:
sovy888 wrote:
wasn't the co supposed to release test results early July?? we are mid July now and late July as of next week! what's going on , any clues???

 
June and July are two very busy months for assay labs. It is a timely process to ensure accurate numbers.

There is a high likelihood of a Monday morning news release. Shorting will be risky if the assays are good. A Wednesday release would be superb as shorters will have a harder time closing their positions before Friday.


I wouldnt count on any further details from the trial results lifting the SP. The meat n potatoes of the trial are known now. Thats why the last NR didnt do anything. The next major news will be regarding Phase II trials and how its to be financed: raise capital through share issuance or some sort of partnership? No word has been given when any milestone payments are due from IMNP. That would be good if we had more details. Personally, I think it's going to be awhile before we hear anything. I'm sure they have rough plans for a Phase II trial but they will need more time to put a complete plan together. I'm thinkinig late fall till any further news of substance, barring a surprise milestone payment
<< Previous
Bullboard Posts
Next >>